RWE and RWD provide key insights to drug discovery and development, coupled with intelligent data management and analytics, MASORI can help the accelerated development of drugs. Our algorithms are crafted to crawl, prepare and analyze Real World Metrics and put them into action.
Our proprietary AI platforms analyze vast datasets like EMR/EHR records, payer data, and claims data to generate actionable insights. These insights drive timely interventions, predict patient needs, and enhance decision-making for HCPs.
MASORI GO revolutionizes AI development by eliminating complexity, enabling businesses to create and deploy generative AI solutions without the need for extensive coding expertise. Designed for seamless integration into existing systems, MASORI GO empowers organizations to harness the power of AI for enhanced decision-making, automation, and customer engagement. Whether optimizing workflows, enhancing natural language understanding, or generating high-accuracy insights, our platform accelerates innovation while reducing costs and time-to-market.
MASORI GO democratizes AI, making cutting-edge technology accessible to businesses of all sizes and industries, driving efficiency, innovation, and competitive advantage.
Real-World Evidence (RWE) is clinical data collected from real-world sources like electronic health records (EHR), insurance claims, and patient registries. It helps pharmaceutical companies and healthcare providers:
MASORI’s AI-driven platforms analyze massive datasets like patient records, clinical trials, and insurance claims to:
This leads to better engagement, faster diagnoses, and improved patient care.
MASORI GO is a no-code AI platform that allows businesses to use AI without coding expertise. Benefits include:
MASORI GO seamlessly connects with CRM platforms, databases, APIs, and cloud services. This ensures smooth AI implementation without disrupting your existing operations.
Yes! MASORI follows strict security and regulatory standards (HIPAA, GDPR, and FDA compliance) to protect patient data, research insights, and business operations.